Manulife (Manufacturers Life Insurance)’s Janux Therapeutics JANX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$166K	Sell	11,963 -24,592	-67%	-$337K	﹤0.01%	2513
2025 Q4	$505K	Sell	36,555 -28,433	-44%	-$669K	﹤0.01%	2171
2025 Q3	$1.59M	Sell	64,988 -9,752	-13%	-$237K	﹤0.01%	1615
2025 Q2	$1.73M	Buy	74,740 +5,995	+9%	+$158K	﹤0.01%	1552
2025 Q1	$1.86M	Buy	68,745 +5,233	+8%	+$197K	﹤0.01%	1516
2024 Q4	$3.4M	Buy	63,512 +32,917	+108%	+$1.74M	﹤0.01%	1350
2024 Q3	$1.39M	Buy	30,595 +6,547	+27%	+$285K	﹤0.01%	1741
2024 Q2	$1.01M	Buy	24,048 +16,864	+235%	+$792K	﹤0.01%	1860
2024 Q1	$270K	Buy	+7,184	New	+$156K	﹤0.01%	2444

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s JANX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Janux Therapeutics (JANX) stake by 67% in Q1 2026, selling an estimated $337K and leaving 11,963 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Manulife (Manufacturers Life Insurance) first reported a position in JANX in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.4M in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 11,963 shares of Janux Therapeutics worth $166K as of Q1 2026.
Manulife (Manufacturers Life Insurance) sold 24,592 Janux Therapeutics shares in Q1 2026, an estimated $337K.
Janux Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2513 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Janux Therapeutics in Q1 2024 and has held it in 9 quarters since.
Manulife (Manufacturers Life Insurance)'s Janux Therapeutics position peaked at $3.4M in Q4 2024.
190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.